Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Shire to customise MicroHealth's app for haemphilia patients

Will collaborate with the digital health firm on its mobile monitoring tool

Shire MicroHealth haemophilia

Shire has signed up to offer haemophilia patients with a free customised version of a widely-used secure care monitoring mobile app.

The firm is collaborating with digital health company MicroHealth to produce a new version of its app, also called MicroHealth.

This will be tailored with new features and information for the 5-7% of haemophilia patients that have inhibitors, a serious that can occur when the immune system prevents standard haemophilia treatments from working.

Shire’s US haematology head Patty Torr, said: “At Shire, we want to do everything we can to help people manage their hemophilia and to limit the burden of the disease on their everyday lives.

“Enhancing the existing MicroHealth app with new functionality and resources to address the needs of hemophilia patients with inhibitors is an important innovation for this group of patients.”

Despite working together on the project, Shire and MicroHealth will remain independent of each other and the pharma firm will not have access to any patient, caregiver or other third-party data through the collaboration.

MicroHealth, a digital health company co-created by a hemophilia patient, originally launched its app in 2011 to help improve haemophilia patient care and outcomes.

The tool allows patients to set reminders, track, store and selectively share personal health data, including photos and bleed alerts, with members of their care team.

MicroHealth co-founder Aaron Craig said: “I created the MicroHealth app with a keen understanding of the challenges and complexities of managing haemophilia based on my own experiences living with severe haemophilia A.

“I wanted to develop a tool that would help streamline hemophilia care to produce stronger adherence. We’re excited to partner with Shire on extensions to the app to better support patients with inhibitors and their care teams.”

The free MicroHealth app is available globally in both English and Spanish on Apple and Android devices. An estimated 20% of American haemophilia patients on prophylactic treatment are MicroHealth app users, and it has been linked to a meaningful reduction in bleed rates.

29th August 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

MAT offers an information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and...

Latest intelligence

What does programmatic advertising mean for your pharma marketing strategy?
Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns....
Discover who are the most engaging Pharma companies on Twitter
With engagement such a key performance metric we first created a weighted formula, incorporating likes, retweets and replies, which produced an engagement score for each account....
International digital pharma marketing: 10 common problems
Your digital marketing challenges are probably shared by peers in other departments and companies. The good news is that such problems often have simple solutions, or can be avoided completely...

Infographics